Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy

Sep.14
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.

Key Points

  • Shenzhen Smoore Technology and distributors Jupiter Research, Greenlane Holdings, 3Win and Canna Brand Solutions are seeking dismissal of the direct purchasers' per se horizontal conspiracy claim.
  • Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on discounting among authorized distributors; the allegations have not been established by the court.
  • Smoore argues that the arrangements were vertical distribution practices between a manufacturer and individual distributors, not an automatically unlawful agreement among competitors.
  • The litigation forms part of a broader CCELL antitrust MDL; the current motion targets a core claim in the direct-purchaser case rather than seeking dismissal of the entire MDL.

2Firsts

September 14, 2026

According to Law360 on September 10, 2026, Shenzhen Smoore Technology Co., Ltd. and four authorized U.S. distributors of CCELL products have asked a California federal court to permanently dismiss a core antitrust class claim brought by direct purchasers, arguing that the alleged pricing and customer arrangements reflect vertical dealings between a manufacturer and distributors rather than a horizontal price-fixing conspiracy.

The motion was filed on September 4 in the U.S. District Court for the Northern District of California.

The litigation is part of In re: CCell Closed Cannabis Oil Vaporization Systems and Components Products Antitrust Litigation, case No. 3:25-md-03161, before U.S. District Judge Vince Chhabria.

Plaintiffs Allege Minimum Pricing and Customer Allocation

The current dispute involves a second amended consolidated class action complaint brought by direct purchasers Meridian Partners II LLC and Redbud Roots Inc.

Along with Smoore, the defendants include four authorized CCELL distributors: Jupiter Research LLC, Greenlane Holdings Inc., 3Win Corp. and CB Solutions LLC, which does business as Canna Brand Solutions.

The plaintiffs allege that Smoore used its position in the cannabis vaping hardware market to organize and enforce pricing and customer arrangements among its authorized distributors.

According to the complaint, distributors agreed to minimum wholesale prices, refrained from competing for certain customers and avoided undercutting one another on price. Plaintiffs also allege that Smoore required authorized distributors to sell only CCELL products and barred them from carrying rival vaping products.

The plaintiffs seek to characterize the arrangements as a horizontal agreement among competitors subject to the Sherman Act's per se rule, under which certain forms of price-fixing and customer allocation can be treated as unlawful without a broader inquiry into market effects.

Those allegations have not been established by the court.

Smoore Says Conduct Was Vertical Distribution Management

Smoore and the four distributors dispute that characterization.

In their dismissal motion, the defendants argue that the second amended complaint still describes separate business relationships between Smoore and individual distributors rather than an agreement among the distributors themselves.

They characterize the alleged arrangements as textbook vertical conduct and say the documents cited by the plaintiffs show how Smoore operated its distribution system, not that competing distributors reached a horizontal agreement.

The distinction matters to the antitrust analysis.

Price-fixing or customer-allocation agreements among competitors can fall within the per se rule, while restrictions imposed in vertical manufacturer-distributor relationships generally require a broader assessment of their competitive effects.

The central dispute is therefore whether CCELL's U.S. distribution structure amounted to vertical channel management or whether Smoore coordinated a horizontal agreement among distributors.

2018 Meeting Again Cited by Plaintiffs

The latest complaint also relies on allegations concerning a 2018 meeting involving the defendants as evidence of coordination among distributors.

Smoore and the distributors argue that the meeting allegations had previously been presented to the court and still do not establish a horizontal agreement.

The defendants are also asking the court not to give the plaintiffs another opportunity to amend the claim.

The court previously dismissed a similar per se horizontal conspiracy claim brought by the direct purchasers. That ruling did not terminate the broader CCELL multidistrict litigation.

Proposed Class Reaches Back to at Least 2016

The proposed direct-purchaser class seeks to represent buyers of unfilled CCELL vaporization systems and components in the United States and its territories from at least December 1, 2016, through the period in which the alleged effects of the purported conspiracy continued.

The plaintiffs seek nationwide relief, including treble damages, attorneys' fees and injunctive relief.

The larger MDL also includes similar claims brought by consumers and other indirect purchasers.

The cases were centralized in the Northern District of California for coordinated proceedings and involve allegations concerning CCELL pricing, distribution restrictions, competing products and relationships among market participants.

The September 4 motion therefore does not seek dismissal of the entire MDL. It targets the direct purchasers' renewed per se horizontal conspiracy theory.

CCELL Distribution Practices Face Antitrust Test

CCELL is one of Smoore's major hardware brands serving cannabis-oil vaporization applications.

The litigation places several common channel-management practices under U.S. antitrust scrutiny, including minimum pricing, customer boundaries among authorized distributors and restrictions involving competing products.

The plaintiffs contend that those practices went beyond separate manufacturer-distributor relationships and became a Smoore-coordinated horizontal arrangement among distributors. Smoore is asking the court to treat the conduct as vertical distribution management and dismiss the per se claim.

The court's handling of the second amended complaint and the latest dismissal motion will determine whether the direct purchasers can continue pursuing this part of the case under a horizontal price-fixing and customer-allocation theory.

Follow 2Firsts for timely updates on global tobacco and nicotine industry developments, corporate strategy and market trends.

Cover Image: ccell

Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor Ron DeSantis announced an expansion of Temporary Assistance for Needy Families (TANF) restrictions that would prohibit Electronic Benefit Transfer (EBT) funds from being used to purchase tobacco and vaping products. The state will amend its TANF State Plan and submit the changes for federal approval. Florida officials said the restrictions would not affect eligibility for temporary cash assistance or the amount of benefits received, but would change how funds can be spent.
Aug.25
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia’s government has withdrawn its appeal against a High Court ruling concerning the regulatory status of liquid nicotine used in vape and e-cigarette products, according to reports by New Straits Times, Free Malaysia Today and CodeBlue on August 18, 2026. The Kuala Lumpur High Court ruled on May 15 that the government’s decision to remove liquid nicotine from the scheduled poisons list under the Poisons Act 1952 was irrational and made without proper consultation with the Poisons Board. The withdrawal ends the government’s appeal process, while the future regulatory framework for nicotine vape products remains under discussion.
Aug.21
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
Switzerland Tightens Vape Checks as Only 3 of 32 Tested Products Meet New Tobacco Rules
Switzerland Tightens Vape Checks as Only 3 of 32 Tested Products Meet New Tobacco Rules
According to Swiss media outlet Blick, local authorities are strengthening compliance checks on vape products, nicotine pouches and other tobacco-related products following the implementation of Switzerland’s revised Tobacco Products Act. A Basel laboratory tested 32 disposable vapes and e-liquids, with only three meeting regulatory requirements and 21 products banned from sale. Swiss authorities are also expanding retail inspections, laboratory testing and youth purchase checks to enforce the new tobacco and nicotine product rules.
Aug.12